AUTIFONY THERAPEUTICS LIMITED
STEVENAGE NEWINCCO 1091 LIMITED

Hellopages » Hertfordshire » Stevenage » SG1 2FX

Company number 07543962
Status Active
Incorporation Date 25 February 2011
Company Type Private Limited Company
Address STEVENAGE BIOSCIENCE CATALYST, GUNNELS WOOD ROAD, STEVENAGE, HERTFORDSHIRE, ENGLAND, SG1 2FX
Home Country United Kingdom
Nature of Business 72110 - Research and experimental development on biotechnology
Phone, email, etc

Since the company registration seventy-two events have happened. The last three records are Group of companies' accounts made up to 31 December 2016; Statement of capital following an allotment of shares on 7 March 2017 GBP 26,976.864 ; Confirmation statement made on 25 February 2017 with updates. The most likely internet sites of AUTIFONY THERAPEUTICS LIMITED are www.autifonytherapeutics.co.uk, and www.autifony-therapeutics.co.uk. The predicted number of employees is 1 to 10. The company’s age is fourteen years and ten months. Autifony Therapeutics Limited is a Private Limited Company. The company registration number is 07543962. Autifony Therapeutics Limited has been working since 25 February 2011. The present status of the company is Active. The registered address of Autifony Therapeutics Limited is Stevenage Bioscience Catalyst Gunnels Wood Road Stevenage Hertfordshire England Sg1 2fx. . BERRIMAN, John is a Director of the company. BHAMAN, Maina is a Director of the company. BINGHAM, Catherine Elizabeth is a Director of the company. JONES, Elaine, Dr is a Director of the company. LARGE, Charles is a Director of the company. PANDE, Atul, Dr is a Director of the company. Secretary OLSWANG COSEC LIMITED has been resigned. Director ALVARO, Giuseppe has been resigned. Director BAXTER, Allan has been resigned. Director MACKIE, Christopher Alan has been resigned. Director OLSWANG DIRECTORS 1 LIMITED has been resigned. Director OLSWANG DIRECTORS 2 LIMITED has been resigned. The company operates in "Research and experimental development on biotechnology".


Current Directors

Director
BERRIMAN, John
Appointed Date: 23 May 2011
77 years old

Director
BHAMAN, Maina
Appointed Date: 19 August 2011
53 years old

Director
BINGHAM, Catherine Elizabeth
Appointed Date: 19 August 2011
60 years old

Director
JONES, Elaine, Dr
Appointed Date: 14 February 2013
70 years old

Director
LARGE, Charles
Appointed Date: 23 May 2011
58 years old

Director
PANDE, Atul, Dr
Appointed Date: 01 April 2014
71 years old

Resigned Directors

Secretary
OLSWANG COSEC LIMITED
Resigned: 23 May 2011
Appointed Date: 25 February 2011

Director
ALVARO, Giuseppe
Resigned: 19 August 2011
Appointed Date: 23 May 2011
61 years old

Director
BAXTER, Allan
Resigned: 27 January 2015
Appointed Date: 19 August 2011
75 years old

Director
MACKIE, Christopher Alan
Resigned: 23 May 2011
Appointed Date: 25 February 2011
65 years old

Director
OLSWANG DIRECTORS 1 LIMITED
Resigned: 23 May 2011
Appointed Date: 25 February 2011

Director
OLSWANG DIRECTORS 2 LIMITED
Resigned: 23 May 2011
Appointed Date: 25 February 2011

Persons With Significant Control

Svls Life Sciences Fund V Lp
Notified on: 6 April 2016
Nature of control: Ownership of shares – More than 25% but not more than 50%

Imperial Innovations Businesses Llp
Notified on: 6 April 2016
Nature of control: Ownership of shares – More than 25% but not more than 50%

AUTIFONY THERAPEUTICS LIMITED Events

10 May 2017
Group of companies' accounts made up to 31 December 2016
27 Mar 2017
Statement of capital following an allotment of shares on 7 March 2017
  • GBP 26,976.864

11 Mar 2017
Confirmation statement made on 25 February 2017 with updates
23 Feb 2017
Registered office address changed from Imperial College Incubator Level 1, Bessemer Building Imperial College London SW7 2AZ United Kingdom to Stevenage Bioscience Catalyst Gunnels Wood Road Stevenage Hertfordshire SG1 2FX on 23 February 2017
10 Oct 2016
Group of companies' accounts made up to 31 December 2015
...
... and 62 more events
26 May 2011
Termination of appointment of Olswang Directors 1 Limited as a director
26 May 2011
Termination of appointment of Olswang Directors 2 Limited as a director
26 May 2011
Termination of appointment of Christopher Mackie as a director
26 May 2011
Resolutions
  • RES13 ‐ Sub-division of shares 23/05/2011

25 Feb 2011
Incorporation

AUTIFONY THERAPEUTICS LIMITED Charges

23 January 2012
Deed of charge over credit balances
Delivered: 9 February 2012
Status: Outstanding
Persons entitled: Barclays Bank PLC
Description: The charge creates a fixed charge over all the deposit(s)…